Nicotine Patches, Gum No Help (CME/CE)

(MedPage Today) — Smokers are no more likely to give up cigarettes for good by using nicotine replacement products such as patches and gum than if they did not use those quit-smoking aids, a prospective cohort study showed.

ACTF, Merck announce new HIV initiatives

Today, Merck, known as MSD outside the United States and Canada, and the ADAP Crisis Task Force (ACTF) announced a number of new initiatives to help struggling state AIDS Drug Assistance Programs (ADAPs) continue to provide access to medicines to people living with HIV.

Vacc-4x nasal vaccine can effectively treat HIV

Thirty years after AIDS was first described, there is still no effective vaccine against the HIV virus. Worldwide, roughly 33 million people are HIV-positive. Researchers are working to find out whether a HIV vaccine developed by a Norwegian biotech company can be administered nasally.

WHO: HIV Progress Includes 15% Drop in New Infections

A report released today by the World Health Organization highlights advances in the prevention of HIV and AIDS-related deaths worldwide. Medscape Medical News

Mylan’s NDA for Atazanavir Sulfate and Ritonavir Tablets receives tentative FDA approval through PEPFAR

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration through the President’s Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application for Atazanavir Sulfate and Ritonavir Tablets, 300 mg/100 mg.

Cost-Effective HIV Prevention In S. And E. Africa By Scaling-Up Voluntary Male Circumcision

A collection of nine new articles to be published in PLoS Medicine and PLoS ONE, in conjunction with the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United States President’s Emergency Plan for AIDS Relief (PEPFAR), highlights how scaling up voluntary medical male circumcision (VMMC) for HIV prevention in eastern and southern Africa can [...]

Obama should announce scale-up of AIDS treatment programs

Secretary of State Hillary Clinton’s recent speech calling for an “AIDS-free generation” through the use of multiple prevention strategies, including more widespread antiretroviral therapy, “was a dramatic reversal of U.S. policy, which has historically viewed treatment more as a costly expense rather than our most powerful prevention investment,” physician Loretta Ciraldo and Katrina Ciraldo, a [...]

2011 May Be Turning Point in World AIDS Pandemic: UN Report

A United Nations report shows deaths and new HIV infections down 21% since the global peak. WebMD Health News

PEPFAR Scientific Advisory Board report offers six recommended research priorities

This post in the Center for Global Health Policy’s “Science Speaks” blog examines a report by the PEPFAR Scientific Advisory Board (SAB) that offers six recommended treatment and prevention research priorities to U.S. Global AIDS Ambassador Eric Goosby and the Office of the Global AIDS Coordinator (OGAC) to guide future PEPFAR programs.

NIAID’s ACTG and TB Alliance partner to complete moxifloxacin Phase III trial

The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.